DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "In Vitro Fertilization (IVF) Market by Cycle Type and End User - Global Opportunity Analysis and Industry Forecast, 2014 - 2022" report to their offering.
InThe world IVF market accounted for $9,015 million in 2015 and is projected to garner revenues worth $17,714 million by 2022, registering a CAGR of 10.2% over the forecast period.
The growth of the market is attributed to the reduced conceiving rates, delayed pregnancy, changing lifestyle conditions and fertility disorders are the major factors that drive the market growth. Other factors such as favourable reimbursement scenario and delayed parenthood opted by couples due to professional and financial constraints will also help in the growth of the market. On the other hand, barriers such as ethical concerns in particular countries with respect to IVF, high cost of the IVF procedures followed by low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.
Rising initiatives towards commercialization of cost-efficient treatments and emerging medical tourism, mainly in developing nations would offer lucrative growth opportunities for IVF service providers in future. Further, the growing clinical research initiatives for the development of novel IVF technologies would provide a platform for growth of the global IVF market.
- Clinique de la Muette
- DRK Kliniken Berlin
- Heidelberg University Hospital
- Hopital des metallurgists, hopital cochin
- Klinikum Stuttgart
University Medical Center Freiburg
Key Topics Covered:
CHAPTER 1 INTRODUCTION
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 WORLD IN VITRO FERTILIZATION (IVF) MARKET OVERVIEW
CHAPTER 4 NORTH AMERICAN IVF MARKET
CHAPTER 5 EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)
CHAPTER 6 ASIA-PACIFIC IVF MARKET (REVENUE AND NUMBER OF CYCLES)
CHAPTER 7 LAMEA IVF MARKET (REVENUE AND NUMBER OF CYCLES)
For more information about this report visit http://www.researchandmarkets.com/research/r8skm9/in_vitro